Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma. 2007

Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan. t056043b@yokohama-cu.ac.jp

Human tumors are dependent on angiogenesis for growth, and the vascular endothelial growth factor (VEGF) is a major regulator of this process. Bevacizumab (Avastin), a monoclonal antibody directed against VEGF, has shown promise in treating a variety of cancers. In this study, we first examined the anti-tumor effects of bevacizumab on head and neck squamous cell carcinoma (HNSCC). Then we examined the effects of bevacizumab combined with paclitaxel, a chemotherapeutic agent, in HNSCC. This is the first demonstration of the anti-tumor effects of bevacizumab on HNSCC. In vitro, bevacizumab did not show any antiproliferative effects against the HNSCC cell lines. However, in vivo, bevacizumab showed dramatic anti-tumor effects against HNSCC tumor xenografts in mice. In addition, treatment with a bevacizumab-paclitaxel combination resulted in a remarkable inhibition of the HNSCC tumor xenografts, compared to the effects of each agent separately. A decreased blood vessel density and an increased apoptotic index were seen in the shrunken tumors. These results suggest that bevacizumab in combination with paclitaxel could have useful clinical application in HNSCC.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068258 Bevacizumab An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS. Avastin,Bevacizumab-awwb,Mvasi,Bevacizumab awwb
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
February 2010, Oncology reports,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
August 2013, Oral oncology,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
June 2016, Journal of cancer research and clinical oncology,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
January 2015, PloS one,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
September 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
December 2003, Onkologie,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
May 1996, European journal of cancer (Oxford, England : 1990),
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
December 2003, Auris, nasus, larynx,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
April 2014, Seminars in oncology,
Kyoko Fujita, and Daisuke Sano, and Machiko Kimura, and Yukiko Yamashita, and Mariko Kawakami, and Yukari Ishiguro, and Goshi Nishimura, and Hideki Matsuda, and Mamoru Tsukuda
October 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
Copied contents to your clipboard!